Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback